NovoCure Ltd — Director's Dealing 2019

Nov 22, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-11-20

Reporting Person: DOYLE WILLIAM F (Director, Executive Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-20	Ordinary Shares	S	149300	$90.3551	Disposed	660165	Direct
2019-11-20	Ordinary Shares	S	700	$91.01	Disposed	659465	Direct

Footnotes

F1: On November 20, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle, Mr. Doyle sold 149,300 shares in multiple trades at prices ranging from $90.00 to $91.00. The price reported above reflects the weighted average sale price. Mr. Doyle hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Doyle.